(MedPage Today) — Most physician prescribers were satisfied with the FDA’s controversial risk evaluation and mitigation strategy (REMS) program for clozapine, survey data showed.
Among 196 doctors who prescribed clozapine, 64% said the positive…
Source link : https://www.medpagetoday.com/psychiatry/schizophrenia/114204
Author :
Publish date : 2025-02-13 18:51:22
Copyright for syndicated content belongs to the linked Source.
